Cargando…
Structural biology of SARS-CoV-2: open the door for novel therapies
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The discovery of therapy reagents for treating COVID-19 are urgently needed, and the structures of the potential drug-target proteins i...
Autores principales: | Yan, Weizhu, Zheng, Yanhui, Zeng, Xiaotao, He, Bin, Cheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793099/ https://www.ncbi.nlm.nih.gov/pubmed/35087058 http://dx.doi.org/10.1038/s41392-022-00884-5 |
Ejemplares similares
-
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
por: Mudgal, Rajat, et al.
Publicado: (2020) -
The open door /
por: Howard, Blanche Willis, 1847-1898
Publicado: (1889) -
Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
por: Esposito, Giuseppe, et al.
Publicado: (2020) -
Opening doors : idioms in English /
por: Zucaro, Michael A.
Publicado: (1992) -
Structural insights into the catalytic and inhibitory mechanisms of the flavin transferase FmnB in Listeria monocytogenes
por: Zheng, Yanhui, et al.
Publicado: (2022)